Evidence map›Paper›PMID 33678609›Full record

ArticleThe European respiratory journal2021

The burden of progressive fibrotic interstitial lung disease across the UK.

Thomas Simpson, Shaney L Barratt, Paul Beirne, Nazia Chaudhuri, Anjali Crawshaw, Louise E Crowley, Sophie Fletcher, Michael A Gibbons, Philippa Hallchurch, Laura Horgan and 13 more

Registry-linked trialAbstract readLetter
In one paragraph

Article in The European respiratory journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06844331 (ULtrasOund Applicability in the Assessment of Patients With fibRosing Interstitial Lung Disease), which is not on this map. Cited by 41 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06844331 enrolling by invitationnot on this mapstarted 2024, after this paper: background citation

ULtrasOund Applicability in the Assessment of Patients With fibRosing Interstitial Lung Disease (LORD): A Research Protocol of a Single Center, Real-life, Prospective Observational Study

TypeobservationalSponsorOdense University HospitalRan2024 to 2026Enrolled117ConditionsFibrosing Interstitial Lung Diseases, Thoracic UltrasoundArmsThoracic ultrasound
3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. BMJ open · 2026
    Article
  4. Prevalence and Prognostic Impact of Progressive Pulmonary Fibrosis.Tuberculosis and respiratory diseases · 2026
    Review
  5. Progressive pulmonary fibrosis.European radiology · 2026
    Review
  6. Article
  7. Article
  8. Progressive pulmonary fibrosis: the importance of identification and intervention.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  9. Performance Characteristics for Physiological Measures of Progressive Pulmonary Fibrosis.American journal of respiratory and critical care medicine · 2025
    Observational
  10. Article
  11. Review
  12. Article
  13. The lung microbiome in interstitial lung disease.Breathe (Sheffield, England) · 2025
    Review
  14. Air Pollution and Interstitial Lung Disease.Tuberculosis and respiratory diseases · 2025
    Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Towards the adoption of quantitative computed tomography in the management of interstitial lung disease.European respiratory review : an official journal of the European Respiratory Society · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Thomas SimpsonDept of Respiratory Medicine, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Shaney L BarrattBristol Interstitial Lung Disease Service, North Bristol NHS trust, Southmead Hospital, Bristol, UK.ORCID 0000-0003-3067-7349
Paul BeirneLeeds Interstitial Lung Disease Service, St James's University Hospital, Leeds, UK.
Nazia ChaudhuriNorth West Lung Centre, Wythenshawe Hospital, Manchester, UK.
Anjali CrawshawBirmingham Interstitial Lung Disease Unit, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Louise E CrowleyBirmingham Interstitial Lung Disease Unit, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Sophie FletcherUniversity Hospitals Southampton NHS Foundation Trust, Southampton, UK.
Michael A GibbonsSouth West Peninsula ILD Network, Royal Devon and Exeter Foundation NHS Trust, Exeter, UK.
Philippa HallchurchBristol Interstitial Lung Disease Service, North Bristol NHS trust, Southmead Hospital, Bristol, UK.
Laura HorganLeeds Interstitial Lung Disease Service, St James's University Hospital, Leeds, UK.
Ieva JakaityteSouth West Peninsula ILD Network, Royal Devon and Exeter Foundation NHS Trust, Exeter, UK.
Thomas LewisBristol Interstitial Lung Disease Service, North Bristol NHS trust, Southmead Hospital, Bristol, UK.
Tom McLellanDept of Interstitial Lung Disease, Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK.
Katherine J MyallDept of Respiratory Medicine, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Ryan MillerSouth West Peninsula ILD Network, Royal Devon and Exeter Foundation NHS Trust, Exeter, UK.
David J F SmithRoyal Brompton Hospital, London, UK.
Stefan StanelNorth West Lung Centre, Wythenshawe Hospital, Manchester, UK.
Muhunthan ThillaiDept of Interstitial Lung Disease, Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK.ORCID 0000-0003-0430-2017
Fiona ThompsonUniversity Hospitals Southampton NHS Foundation Trust, Southampton, UK.
Timothy WallisUniversity Hospitals Southampton NHS Foundation Trust, Southampton, UK.
Zhe WuRoyal Brompton Hospital, London, UK.ORCID 0000-0002-4910-4965
Philip L MolyneauxRoyal Brompton Hospital, London, UK.ORCID 0000-0003-1301-8800
Alex G WestDept of Respiratory Medicine, Guy's and St Thomas' NHS Foundation Trust, London, UK.ORCID 0000-0001-6110-1508

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Lung Diseases, InterstitialPulmonary FibrosisHumansLungUnited Kingdom

Identifiers

PMID33678609
PMCPMC8264777

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.